Intravenous Labetalol for intracerebral hemorrhage

Recruiting

• Conditions: Blood pressure control and hematoma volume control in patients with spontaneous intracerebral hemorrhage; intracranial hemorrhage; Labetalol; blood pressure; hemorrhagic stroke

• Registration Number: TCTR20240423003
• Lead Sponsor: Faculty of Medicine, Thammasat University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2024-04-23
• Last Update Posted: 19 August 2024
• Study Completion: 2024-10-01

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

1. Spontaneous ICH
2.Age more than 18 years
3. No secondary causes: AVM, aneurysm

Exclusion Criteria

1.Secondary causes of ICH: AVM, aneurysm
2.Pregnancy
3.Traumatic intracerebral hemorrhage

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Safety 24 hours modified Rankin scale

Secondary Outcome Measures

Name	Time	Method
Complications 24 hours Blood pressure less than 90/60 mmHg, Heart rate less than 50 beat per minute,Dosage related to complications 24 hours milligrams per day,Target blood pressure 24 hours Time required for BP to reach target BP/ Hours,Hematoma expansion 24 hours Hematoma volume of more than 33% from baseline